In last trading session, Enveric Biosciences Inc (NASDAQ:ENVB) saw 1.42 million shares changing hands with its beta currently measuring 0.57. Company’s recent per share price level of $3.90 trading at -$0.4 or -9.30% at ring of the bell on the day assigns it a market valuation of $2.70M. That closing price of ENVB’s stock is at a discount of -1023.08% from its 52-week high price of $43.80 and is indicating a premium of 0.51% from its 52-week low price of $3.88. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 24324.0 shares which gives us an average trading volume of 36.36K if we extend that period to 3-months.
Enveric Biosciences Inc (NASDAQ:ENVB) trade information
Upright in the red during last session for losing -9.30%, in the last five days ENVB remained trading in the red while hitting it’s week-highest on Friday, 01/24/25 when the stock touched $3.90 price level, adding 23.53% to its value on the day. Enveric Biosciences Inc’s shares saw a change of -27.46% in year-to-date performance and have moved -21.92% in past 5-day. Enveric Biosciences Inc (NASDAQ:ENVB) showed a performance of -25.07% in past 30-days. Number of shares sold short was 0.33 million shares which calculate 0.31 days to cover the short interests.
Enveric Biosciences Inc (ENVB) estimates and forecasts
Statistics highlight that Enveric Biosciences Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -55.28% of value to its shares in past 6 months, showing an annual growth rate of -289.26% while that of industry is 16.10. Apart from that, the company came lowering its revenue forecast for fiscal year 2025.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 71.22% during past 5 years.
Enveric Biosciences Inc (NASDAQ:ENVB)’s Major holders
Insiders are in possession of 6.93% of company’s total shares while institution are holding 7.06 percent of that, with stock having share float percentage of 7.58%. Investors also watch the number of corporate investors in a company very closely, which is 7.06% institutions for Enveric Biosciences Inc that are currently holding shares of the company. ADVISORSHARES INVESTMENTS LLC is the top institutional holder at ENVB for having 0.32 million shares of worth $0.19 million. And as of 2024-06-30, it was holding 7.9233 of the company’s outstanding shares.
The second largest institutional holder is GEODE CAPITAL MANAGEMENT, LLC, which was holding about 44659.0 shares on 2024-06-30. The number of shares represents firm’s hold over 1.1161 of outstanding shares, having a total worth of $27688.0.
